Global Medical REIT Inc.
Sembol: GMRE
NYSE
9.03
USDBugünkü piyasa fiyatı
30.7150
F/K Oranı
0.5877
PEG Oranı
592.14M
MRK Kapağı
- 0.09%
DIV Verimi
Global Medical REIT Inc. (GMRE) Finansal Tablolar
Bilanço
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 7.4 | 4 | 7.2 | |||||||||||||
balance-sheet.row.short-term-investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.net-receivables | 0 | 33.7 | 8.2 | 6.2 | |||||||||||||
balance-sheet.row.inventory | 0 | -25.1 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-current-assets | 0 | -41.1 | 18.3 | -50.3 | |||||||||||||
balance-sheet.row.total-current-assets | 0 | 14.4 | 30.5 | 24.9 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 7.6 | 3.5 | 3.8 | |||||||||||||
balance-sheet.row.goodwill | 0 | 5.9 | 5.9 | 5.9 | |||||||||||||
balance-sheet.row.intangible-assets | 0 | 66 | 148.1 | 127.9 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 71.9 | 154 | 133.8 | |||||||||||||
balance-sheet.row.long-term-investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.tax-assets | 0 | 1140.3 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 8.5 | 1205.3 | 1100.9 | |||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1253.3 | 1362.7 | 1238.5 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 0 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.account-payables | 0 | 12.8 | 13.8 | 10.3 | |||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.4 | 636.4 | 514.6 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 610.8 | 57.7 | 57.2 | |||||||||||||
Deferred Revenue Non Current | 0 | 5.1 | 4.4 | 3.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 0 | 601.1 | 11.4 | 15.7 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 42.5 | 78.1 | 85.3 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 13 | 10.5 | 8.1 | |||||||||||||
balance-sheet.row.total-liab | 0 | 661.9 | 744.2 | 625.9 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 75 | 75 | 75 | |||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||
balance-sheet.row.retained-earnings | 0 | -239 | -198.7 | -157 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 25.1 | 34.7 | -6.6 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 722.4 | 722 | 711.4 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 583.6 | 633 | 622.8 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 22.2 | 16.1 | 14.8 | |||||||||||||
balance-sheet.row.total-equity | 0 | 605.8 | 649.1 | 637.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||
Total Investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.total-debt | 0 | 624.2 | 694.1 | 571.7 | |||||||||||||
balance-sheet.row.net-debt | 0 | 616.8 | 690.1 | 564.5 |
Nakit Akış Tablosu
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 20.6 | 20 | 18.3 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 58.1 | 57.7 | 47.3 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -122.1 | 0 | -0.9 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 4.2 | 4.7 | 5.8 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -5.7 | -1.7 | -3.8 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0.4 | -3 | -0.7 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0.2 | ||||||||||||
cash-flows.row.account-payables | 0 | -2 | 4.1 | 1.9 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -4.1 | -2.8 | -5.3 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 113.3 | -4.1 | 2.2 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 2 | 2.8 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -2.8 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 86.1 | 11.1 | 4.4 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | -1.3 | 7.8 | 2.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 74.8 | -137.3 | -194.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | -86.1 | -16.7 | -232.2 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 9.9 | 205.5 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 221.6 | ||||||||||||
cash-flows.row.dividends-paid | 0 | -64.8 | -64.2 | -58.3 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 133.4 | -8.9 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -150.9 | 62.4 | 127.7 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -77.5 | 0 | 0 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -14.9 | 1.7 | 2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 7.4 | 14.5 | 12.8 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 22.3 | 12.8 | 10.8 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 68.4 | 76.5 | 69 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | 58.4 | -79.7 | -132.7 |
Gelir Tablosu Satırı
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 156.7 | 137.3 | 115.9 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 86.2 | 25.2 | 15.5 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 70.4 | 112.1 | 100.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 16.9 | 73.3 | 63.3 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 103.1 | 98.5 | 78.8 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 58.1 | 57.7 | 46.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 53.5 | 38.8 | 37.1 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 21.7 | 20 | 18.3 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1.1 | 25.2 | 20.4 | ||||||||||||
income-statement-row.row.net-income | 0 | 20.6 | -5.2 | -2.1 |
Sıkça Sorulan Sorular
Nedir Global Medical REIT Inc. (GMRE) toplam varlıklar?
Global Medical REIT Inc. (GMRE) toplam varlıklar 1267700000.000 şeklindedir.
İşletmenin yıllık geliri nedir?
Yıllık gelir N/A'dur.
Firma kâr marjı nedir?
Firma kar marjı 0.759'dir.
Şirket serbest nakit akışı nedir?
Serbest nakit akışı 0.891'dur.
İşletme net kar marjı nedir?
Net kâr marjı 0.134'dir.
Firma toplam geliri nedir?
Toplam gelir 0.345'dur.
Nedir Global Medical REIT Inc. (GMRE) net kar (net gelir)?
Net kar (net gelir) 20612000.000'dur.
Firmanın toplam borcu nedir?
Toplam borç 624193000.000'dir.
Faaliyet giderleri rakamı nedir?
İşletme giderleri 16897000.000'dır.
Şirket nakit rakamı nedir?
İşletme içi nakit 0.000'tir.